Search

everythinglearnresearchcommunity

for

Search:↓

Transcranial electrical stimulation may help reduce certain immune markers in COVID-19 patients.

DHT may reduce inflammation caused by certain bacteria in skin cells.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Transplant success has improved with better immunosuppressive drugs and donor matching.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Pityriasis rubra pilaris is a rare skin disorder with reddish-orange patches and thickened skin, needing better treatment understanding.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

A rare skin condition was confirmed to be associated with a specific virus in a young girl.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Cyclosporine can cause a unique skin condition called "cyclosporine-induced folliculodystrophy."

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Treating cystoid macular oedema in uveitis is difficult and risky.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

No treatment is completely effective for alopecia totalis and alopecia universalis.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.